- Canine osteoarthritis pain treatment Daxocox launched in second half
- Early-stage R&D agreement signed with Orthros Medical in March
The boom in pet ownership during the pandemic has manifested in stronger sales and profit margins for Animalcare’s (ANCR) veterinary medicines in 2021. The shares rose by 4 per cent on the morning of the results, reversing this year’s vet sector sell-off that has also affected rivals CVS (CVSG) and Dechra Pharmaceuticals (DPH).